JAK1 and breast cancer: On the contrary, a breast cancer study by Chen et al. [58] indicated that overexpression of JAK1 is associated with a favorable prognosis (OS, HR: 0.52, 95% CI: 0.42–0.65, p = 1.5 × 10−9).